{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:10:09Z","timestamp":1772766609631,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The risk of surgical site infections (SSIs), particularly methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) SSIs, after spinal surgeries is one of the most daunting experiences to patients and surgeons. Some authors suggest applying vancomycin powder on the wound before skin closure to minimize the risk of SSIs; however, this practice is not supported by well-established evidence. This study sought to assess the effectiveness of topical (i.e. intra-wound) vancomycin in minimizing the risk of SSIs in patients who underwent spinal surgeries at a Saudi hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted using the hospital database. Patients who underwent spinal surgeries from the period of 09\/2013 to 09\/2019 were included and followed up (observed from the time of the surgery) to 30 days (surgeries without implants) or 90 days (with implants). The odds ratio (OR) of the primary outcome between vancomycin treated versus non-treated patients was estimated using a logistic regression model adjusting for the measured confounders. A sensitivity analysis was conducted using propensity score analysis (inverse probability of treatment weighting [IPTW] with stabilized weights) to control for confounding by indication. All study analyses were completed using RStudio Version 1.2.5033.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 81 vancomycin treated vs. 375 untreated patients with 28 infections (8\/81 vs. 20\/375; respectively). The adjusted OR of SSIs between the two groups was 0.40 (95% confidence interval [CI] 0.11 to 1.34). The result of the propensity score analysis was consistent (OR: 0.97 [95% CI 0.35 to 2.68]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We could not find a lower association of SSIs with intra-wound vancomycin in patients who underwent spinal surgeries. Further studies are needed to assess benefits of using topical vancomycin for this indication vs. the risk of antimicrobial resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-021-01006-6","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T15:02:55Z","timestamp":1632668575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effectiveness of topical vancomycin in the prevention of spinal surgical site infections: a retrospective cohort study"],"prefix":"10.1186","volume":"10","author":[{"given":"Rawan T.","family":"Tafish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed F.","family":"Alkhaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouar","family":"Bourghli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-7963","authenticated-orcid":false,"given":"Turki A.","family":"Althunian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"issue":"3","key":"1006_CR1","first-page":"208","volume":"45","author":"Z Jiaming","year":"2019","unstructured":"Jiaming Z, Wang R. Incidence of surgical site infection after spine surgery: a systematic review and meta-analysis. SPINE. 2019;45(3):208-16.","journal-title":"SPINE"},{"key":"1006_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.otsr.2012.07.006","volume":"98","author":"The French Orthopaedic Surgery Traumatology Society","year":"2012","unstructured":"The French Orthopaedic Surgery Traumatology Society. Early surgical site infections in adult spinal trauma: a prospective, multi-center study of infection rates and risk factors. Orthop Traumatol Surg Res. 2012;98:788\u201394.","journal-title":"Orthop Traumatol Surg Res"},{"key":"1006_CR3","first-page":"154","volume":"6","author":"S Saeedinia","year":"2015","unstructured":"Saeedinia S, Nouri M, Azarhomayoun A, et al. The incidence and risk factors for surgical site infection after clean spinal operations: a prospective cohort study and review of the literature. Surg Neurol Int. 2015;6:154.","journal-title":"Surg Neurol Int."},{"key":"1006_CR4","unstructured":"World Health Organization WHO. Protocol for surgical site infection surveillance with a focus on settings with limited resources. 2018."},{"issue":"3S","key":"1006_CR5","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1093\/neuros\/nyw066","volume":"80","author":"PA Anderson","year":"2017","unstructured":"Anderson PA, Savage JW, Vaccaro AR, et al. Prevention of surgical site infection in spine surgery. Neurosurgery. 2017;80(3S):S114\u201323.","journal-title":"Neurosurgery."},{"issue":"11","key":"1006_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1086\/591861","volume":"29","author":"AI Hidron","year":"2008","unstructured":"Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol. 2008;29(11):996\u20131011.","journal-title":"Infect Control Hosp Epidemiol."},{"key":"1006_CR7","doi-asserted-by":"crossref","unstructured":"ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999;56(18):1839\u201388.","DOI":"10.1093\/ajhp\/56.18.1839"},{"key":"1006_CR8","unstructured":"National Healthcare Safety Network (NHSN). Patient Safety Component Manual. Surgical site infection event. 2019."},{"key":"1006_CR9","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery. 2014."},{"issue":"3","key":"1006_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195\u2013283.","journal-title":"Am J Health Syst Pharm."},{"issue":"8","key":"1006_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berr\u00edos-Torres","year":"2017","unstructured":"Berr\u00edos-Torres SI, Umscheid A, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection. JAMA Surg. 2017;152(8):784\u201391.","journal-title":"JAMA Surg."},{"issue":"1","key":"1006_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1302\/0301-620X.76B1.8300691","volume":"76","author":"E Rubinstein","year":"1994","unstructured":"Rubinstein E, Findler G, Amit P, et al. Perioperative prophylactic cephazolin in spinal surgery: A double-blind placebo controlled trial. J Bone Joint Surg Br. 1994;76(1):99\u2013102.","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"1006_CR13","doi-asserted-by":"publisher","first-page":"106116","DOI":"10.1016\/j.ijantimicag.2020.106116","volume":"56","author":"D Margaryan","year":"2020","unstructured":"Margaryan D, Renz N, Bervar M, et al. Spinal implant-associated infections: a prospective multicentre cohort study. Int J Antimicrob Agents. 2020;56(4):106116.","journal-title":"Int J Antimicrob Agents"},{"issue":"24","key":"1006_CR14","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","volume":"36","author":"FA Sweet","year":"2011","unstructured":"Sweet FA, Roh M, Sliva C. Intra-wound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011;36(24):2084\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"1006_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.spinee.2011.04.025","volume":"11","author":"KR O\u2019Neill","year":"2011","unstructured":"O\u2019Neill KR, Smith JG, Abtahi AM, et al. Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J. 2011;11(7):641\u20136.","journal-title":"Spine J"},{"issue":"14","key":"1006_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/BRS.0b013e31828fcfb5","volume":"38","author":"C Caroom","year":"2013","unstructured":"Caroom C, Tullar JM, Benton Jr EG, et al. Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion. Spine (Phila Pa 1976). 2013;38(14):1183\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"1006_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2106\/JBJS.K.00756","volume":"95","author":"JM Pahys","year":"2013","unstructured":"Pahys JM, Pahys JR, Cho SK, et al. Methods to decrease postoperative infections following posterior cervical spine surgery. J Bone Joint Surg Am. 2013;95(6):549\u201354.","journal-title":"J Bone Joint Surg Am."},{"issue":"25","key":"1006_CR18","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1097\/BRS.0000000000000015","volume":"38","author":"VR Tubaki","year":"2013","unstructured":"Tubaki VR, Rajasekaran S, Shetty AP. Effects of using intravenous antibiotic only versus local intra-wound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine (Phila Pa 1976). 2013;38(25):2149\u201355.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"1006_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.14245\/kjs.2013.10.3.121","volume":"10","author":"HS Kim","year":"2013","unstructured":"Kim HS, Lee SG, Kim WK, et al. Prophylactic intra-wound application of vancomycin powder in instrumented spinal fusion surgery. Korean J Spine. 2013;10(3):121\u20135.","journal-title":"Korean J Spine."},{"issue":"9","key":"1006_CR20","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.clineuro.2013.04.005","volume":"115","author":"RG Strom","year":"2013","unstructured":"Strom RG, Pacione D, Kalhorn SP, et al. Lumbar laminectomy and fusion with routine local application of vancomycin powder: decreased infection rate in instrumented and non-instrumented cases. Clin Neurol Neurosurg. 2013;115(9):1766\u20139.","journal-title":"Clin Neurol Neurosurg."},{"key":"1006_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/BRS.0b013e318285b219","volume":"38","author":"RG Strom","year":"1976","unstructured":"Strom RG, Pacione D, Kalhorn SP, et al. Decreased risk of wound infection after posterior cervical fusion with routine local application of vancomycin powder. Spine (Phila Pa 1976). 2013;38:991\u20134.","journal-title":"Spine (Phila Pa 1976)."},{"issue":"3","key":"1006_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3171\/2013.6.SPINE121105","volume":"19","author":"SS Godil","year":"2013","unstructured":"Godil SS, Parker SL, O\u2019Neill KR, et al. Comparative effectiveness and cost-benefit analysis of local application of vancomycin powder in posterior spinal fusion for spine trauma: clinical article. J Neurosurg Spine. 2013;19(3):331\u20135.","journal-title":"J Neurosurg Spine."},{"key":"1006_CR23","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/BRS.0000000000000533","volume":"39","author":"AA Theologis","year":"2014","unstructured":"Theologis AA, Demirkiran G, Callahan M, et al. Local intra-wound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: a cost analysis. Spine (Phila Pa 1976). 2014;39:1875\u201380.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00701-014-2022-z","volume":"156","author":"BW Hill","year":"2014","unstructured":"Hill BW, Emohare O. The use of vancomycin powder reduces surgical reoperation in posterior instrumented and non-instrumented spinal surgery. Acta Neurochir (Wien). 2014;156:749\u201354.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"1006_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/BRS.0000000000000071","volume":"39","author":"JR Martin","year":"2014","unstructured":"Martin JR, Adogwa O, Brown CR, et al. Experience with intra-wound vancomycin powder for spinal deformity surgery. Spine (Phila Pa 1976). 2014;39(2):177\u201384.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/BRS.0000000000000241","volume":"39","author":"GM Ghobrial","year":"2014","unstructured":"Ghobrial GM, Thakkar V, Andrews E, et al. Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine (Phila Pa 1976). 2014;39)(7):550\u20135.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"10","key":"1006_CR27","doi-asserted-by":"publisher","first-page":"E584-9","DOI":"10.1097\/BSD.0000000000000045","volume":"28","author":"A Heller","year":"2015","unstructured":"Heller A, McIff TE, Lai SM, et al. Intrawound vancomycin powder decreases Staphylococcal surgical site infections after posterior instrumented spinal arthrodesis. J Spinal Disord Tech. 2015;28(10):E584\u20139.","journal-title":"J Spinal Disord Tech"},{"issue":"7","key":"1006_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/BRS.0000000000000789","volume":"40","author":"M Tomov","year":"2015","unstructured":"Tomov M, Mitsunaga L, Durbin-Johnson B, et al. Reducing surgical site infection in spinal surgery with betadine irrigation and intra-wound vancomycin powder. Spine (Phila Pa 1976). 2015;40(7):491\u20139.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"1006_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3171\/2014.9.SPINE13826","volume":"22","author":"JR Martin","year":"2015","unstructured":"Martin JR, Adogwa O, Brown CR, et al. Experience with intrawound vancomycin powder for posterior cervical fusion surgery. J Neurosurg Spine. 2015;22(1):26\u201333.","journal-title":"J Neurosurg Spine"},{"issue":"20","key":"1006_CR30","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1097\/BRS.0000000000001133","volume":"40","author":"N Liu","year":"2015","unstructured":"Liu N, Wood KB, Schwab JH, et al. Comparison of intra-wound vancomycin utility in posterior instrumented spine surgeries between patients with tumor and non-tumor patients. Spine (Phila Pa 1976). 2015;40(20):1586\u201392.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14245\/kjs.2016.13.2.47","volume":"13","author":"GI Lee","year":"2016","unstructured":"Lee GI, Bak KH, Chun HJ, et al. Effect of using local intra-wound vancomycin powder in addition to intravenous antibiotics in posterior lumbar surgery: midterm result in a single-center study. Korean J Spine. 2016;13:47\u201352.","journal-title":"Korean J Spine"},{"issue":"1","key":"1006_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/phar.1678","volume":"36","author":"A Gaviola","year":"2016","unstructured":"Gaviola A, McMillian WD, Ames SE, et al. A retrospective study on the protective effects of topical vancomycin in patients undergoing multilevel spinal fusion. Pharmacotherapy. 2016;36(1):19-25.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"1006_CR33","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00586-015-4119-3","volume":"25","author":"JE Schroeder","year":"2016","unstructured":"Schroeder JE, Girardi FP. The use of local vancomycin powder in degenerative spine surgery. Eur Spine J. 2016;25(4):1029\u201333.","journal-title":"Eur Spine J"},{"issue":"5","key":"1006_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/neuros\/nyw097","volume":"80","author":"S Chotai","year":"2017","unstructured":"Chotai S, Wright PW, Hale AT, et al. Does intrawound vancomycin application during spine surgery create vancomycin-resistant organism? Neurosurgery. 2017;80(5):746\u201353.","journal-title":"Neurosurgery"},{"key":"1006_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/BRS.0000000000001710","volume":"42","author":"HW Hey","year":"2017","unstructured":"Hey HW, Thiam DW, Koh ZSD, et al. Is intraoperative local vancomycin powder the answer to surgical site infections in spine surgery? Spine (Phila Pa 1976). 2017;42(4):267-74.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR36","doi-asserted-by":"publisher","first-page":"E1062","DOI":"10.1097\/BSD.0000000000000516","volume":"30","author":"M Van Hal","year":"2017","unstructured":"Van Hal M, Lee J, Laudermilch D, et al. Vancomycin powder regimen for prevention of surgical site infection in complex spine surgeries. Clin Spine Surg. 2017;30:E1062\u20135.","journal-title":"Clin Spine Surg"},{"key":"1006_CR37","first-page":"545","volume":"79","author":"T Hida","year":"2017","unstructured":"Hida T, Ando K, Kobayashiet K, et al. Intrawound vancomycin powder as the prophylaxis of surgical site infection after invasive spine surgery with a high risk of infection. Nagoya J Med Sci. 2017;79:545\u201350.","journal-title":"Nagoya J Med Sci."},{"key":"1006_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12306-017-0526-4","volume":"102","author":"B Mirzashahi","year":"2018","unstructured":"Mirzashahi B, Chehrassan M, Mortazavi SMJ. Intrawound application of vancomycin changes the responsible germ in elective spine surgery without significant effect on the rate of infection: a randomized prospective study. Musculoskelet Surg. 2018;102:35\u20139.","journal-title":"Musculoskelet Surg"},{"issue":"12","key":"1006_CR39","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.spinee.2018.04.015","volume":"18","author":"C Horii","year":"2018","unstructured":"Horii C, Yamazaki T. Does intrawound vancomycin powder reduce surgical site infection after posterior instrumented spinal surgery? A propensity score-matched analysis. Spine J. 2018;18(12):2205\u201312.","journal-title":"Spine J"},{"issue":"5","key":"1006_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jspd.2018.01.010","volume":"6","author":"G Sumeet","year":"2018","unstructured":"Sumeet G, Bloch N, Potter M, et al. Topical vancomycin in pediatric spine surgery does not reduce surgical site infection: a retrospective cohort study. Spine Deform. 2018;6(5):523\u20138.","journal-title":"Spine Deform."},{"issue":"2","key":"1006_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3171\/2017.12.SPINE17997","volume":"29","author":"S Haimoto","year":"2018","unstructured":"Haimoto S, Sch\u00e4r RT, Nishimura Y, et al. Reduction in surgical site infection with supra-fascial intra-wound application of vancomycin powder in instrumented posterior spinal fusion: a retrospective case-control study. J Neurosurg Spine. 2018;29(2):193\u20138.","journal-title":"J Neurosurg Spine."},{"key":"1006_CR42","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2018.10.FOCUS18470","volume":"1","author":"V Dodson","year":"2019","unstructured":"Dodson V, Majmundar N, Swantic V, et al. The effect of prophylactic vancomycin powder on infections following spinal surgeries: a systematic review. Neurosurg Focus. 2019;1:E11.","journal-title":"Neurosurg Focus."},{"issue":"6","key":"1006_CR43","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.spinee.2019.01.002","volume":"19","author":"A Gande","year":"2019","unstructured":"Gande A, Rosinski A, Cunningham T, et al. Selection pressures of vancomycin powder use in spine surgery: a meta-analysis. Spine J. 2019;19(6):1076\u201384.","journal-title":"Spine J."},{"key":"1006_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3171\/2018.3.SPINE171111","volume":"29","author":"M Takeuchi","year":"2018","unstructured":"Takeuchi M, Wakao N, Mitsuhiro K, et al. A double-blind randomized controlled trial of the local application of vancomycin versus ampicillin powder into the operative field for thoracic and\/or lumbar fusions. J Neurosurg Spine. 2018;29:553\u20139.","journal-title":"J Neurosurg Spine."},{"issue":"5","key":"1006_CR45","volume":"13","author":"SA Alhunaif","year":"2021","unstructured":"Alhunaif SA, Almansour S, Almutairi R, et al. Methicillin-Resistant Staphylococcus Aureus Bacteremia: Epidemiology, Clinical Characteristics, Risk Factors, and Outcomes in a Tertiary Care Center in Riyadh, Saudi Arabia. Cureus. 2021;13(5):e14934.","journal-title":"Cureus."},{"key":"1006_CR46","unstructured":"Center for Disease Control and Prevention. Surgical site infections. 2010. https:\/\/www.cdc.gov\/hai\/ssi\/ssi.html. Accessed Aug 2021."},{"issue":"11","key":"1006_CR47","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2106\/00004623-200311000-00004","volume":"85","author":"Y Leah","year":"2003","unstructured":"Carreon LY, Puno RM, Dimar 2nd JR, et al. Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. Am J Bone Joint Surg. 2003;85(11):2089\u201392.","journal-title":"Am J Bone Joint Surg"},{"key":"1006_CR48","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/BRS.0b013e3181a03013","volume":"34","author":"AFP ter Gunne","year":"2009","unstructured":"ter Gunne AFP, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine. 2009;34:1422\u20138.","journal-title":"Spine"},{"key":"1006_CR49","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2147\/TCRM.S181477","volume":"14","author":"L Zhang","year":"2018","unstructured":"Zhang L, Li N. Risk factors for surgical site infection following lumbar spinal surgery: a meta-analysis. Ther Clin Risk Manag. 2018;14:2161\u20139.","journal-title":"Ther Clin Risk Manag"},{"key":"1006_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2106\/JBJS.J.01084","volume":"94","author":"AM Cizik","year":"2012","unstructured":"Cizik AM, Lee MJ, Martin BI, et al. Using the Spine Surgical Invasiveness Index to identify risk of surgical site infection. Am J Bone Joint Surg. 2012;94(4):335\u201342.","journal-title":"Am J Bone Joint Surg"},{"key":"1006_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BRS.0000000000000655","volume":"40","author":"R De la Garza-Ramos","year":"2014","unstructured":"De la Garza-Ramos R, Bydon M, Abt NB, et al. The impact of obesity on short- and long-term outcomes after lumbar fusion. Spine (Phila Pa 1976). 2014;40(1):56\u201361.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR52","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/BRS.0000000000000232","volume":"39","author":"A Marquez-Lara","year":"2014","unstructured":"Marquez-Lara A, Nandyala SV, Sankaranarayanan S, et al. Body mass index as a predictor of complications and mortality after lumbar spine surgery. Spine (Phila Pa 1976). 2014;39(10):798\u2013804.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/BRS.0000000000001281","volume":"41","author":"CT Martin","year":"2016","unstructured":"Martin CT, Gao Y, Duchman KR, et al. The impact of current smoking and smoking cessation on short-term morbidity risk after lumbar spine surgery. Spine (Phila Pa 1976). 2016;41(7):577\u201384.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1006_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2106\/JBJS.F.01515","volume":"90","author":"MA Olsen","year":"2008","unstructured":"Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. Am J Bone Joint Surg. 2008;90(1):62\u20139.","journal-title":"Am J Bone Joint Surg"},{"issue":"2","key":"1006_CR55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/2192568218819817","volume":"10","author":"K Atesok","year":"2020","unstructured":"Atesok K, Papavassiliou E, Heffernan MJ, et al. Current strategies in prevention of postoperative infections in spine surgery. Global Spine J. 2020;10(2):183\u201394.","journal-title":"Global Spine J."},{"key":"1006_CR56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/430910","volume":"41","author":"AI Hidron","year":"2005","unstructured":"Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005;41(2):159\u201366.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1006_CR57","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1086\/605323","volume":"30","author":"KM Boston","year":"2009","unstructured":"Boston KM, Baraniuk S, O\u2019Heron S, et al. Risk factors for spinal surgical site infection, Houston, Texas. Infect Control Hosp Epidemiol. 2009;30(9):884\u20139.","journal-title":"Infect Control Hosp Epidemiol."},{"key":"1006_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/2192568217699378","volume":"7","author":"NJ Lee","year":"2017","unstructured":"Lee NJ, Shin JI, Kothari P, et al. Incidence, impact, and risk factors for 30-day wound complications following elective adult spinal deformity surgery. Global Spine J. 2017;7(5):417\u201324.","journal-title":"Global Spine J"},{"key":"1006_CR59","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/BRS.0b013e3181eadd41","volume":"36","author":"JS -Smith","year":"2011","unstructured":"Smith JS, Shaffrey CI, Sansur CA, et al. Rates of infection after spine surgery based on 108,419 procedures: a report from the scoliosis research society morbidity and mortality committee. Spine (Phila Pa 1976). 2011;36(7):556-63.","journal-title":"Spine"},{"key":"1006_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355.","journal-title":"Biometrika"},{"key":"1006_CR61","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516\u201324.","journal-title":"J Am Stat Assoc"},{"key":"1006_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hern\u00e1n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656\u201364.","journal-title":"Am J Epidemiol"},{"key":"1006_CR63","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fphar.2019.00973","volume":"10","author":"MS Ali","year":"2019","unstructured":"Ali MS, Prieto-Alhambra D, Lopes LC, et al. Propensity score methods in health technology assessment: principles, extended applications, and recent advances. Front Pharmcol. 2019;10:973.","journal-title":"Front Pharmcol"},{"issue":"Supp 39","key":"1006_CR64","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4103\/2152-7806.195227","volume":"7","author":"KG Abdullah","year":"2016","unstructured":"Abdullah KG, Chen HI, Lucas TH. Safety of topical vancomycin powder in neurosurgery. Surg Neuro Int. 2016;7(Supp 39):919\u201326.","journal-title":"Surg Neuro Int"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-021-01006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-021-01006-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-021-01006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T16:13:18Z","timestamp":1632672798000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-021-01006-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1006"],"URL":"https:\/\/doi.org\/10.1186\/s13756-021-01006-6","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"12 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A protocol for the study was submitted to the Institutional Review Board (IRB) at the hospital and an approval was granted on 5\/2019 by the IRB. The views expressed in this paper are those of the author(s) and not do not necessarily reflect those of the SFDA or its stakeholders.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}